A Comparison of Methods for Tracking Progression in X-Linked Retinitis Pigmentosa Using Frequency Domain OCT

被引:38
|
作者
Ramachandran, Rithambara [1 ]
Zhou, Lisa [1 ]
Locke, Kirsten G. [2 ]
Birch, David G. [2 ]
Hood, Donald C. [1 ,3 ]
机构
[1] Columbia Univ, Dept Psychol, 406 Schermerhorn Hall,1190 Amsterdam Ave,MC 5501, New York, NY 10027 USA
[2] Retina Fdn Southwest, Dallas, TX USA
[3] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA
来源
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY | 2013年 / 2卷 / 07期
关键词
retinitis pigmentosa; optical coherence tomography; progression;
D O I
10.1167/tvst.2.7.5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the efficacy of frequency domain optical coherence tomography (fdOCT)-derived outer retinal measures in tracking disease progression in x-linked (xl) retinitis pigmentosa (RP) patients. Methods: Macular volume scans and line scans (Spectralis) were obtained from 27 xlRP patients (15.3 +/- 6.4 years) at two visits approximately 2 years apart. Changes in average outer retinal layer thicknesses across the volume scan were compared to changes detected by measures derived from the edge of the inner segment ellipsoid zone (EZ) band, that is, where the EZ band (also known as inner segment/outer segment border) disappears. Repeatability was tested on an independent set of 18 RP patients (43.5 +/- 18.0 years). Results: Average outer segment (OS) and outer nuclear layer (ONL) thickness showed marginally significant annual changes (P < 0.05), while total receptor (TR) thickness showed a greater change (P < 0.01). All measures derived from the edge of the EZ band significantly decreased (P < 0.01). Mean +/- SD for test-retest differences in horizontal widths was 0.01 +/- 0.06 mm. Conclusions: Measures of the EZ band are more effective in detecting disease progression than are thickness measures. Given the similar effectiveness of line and volume scans, manually marking the EZ band edge on vertical and/or horizontal line scans can be useful in tracking progression. Translational Relevance: Because disease progression in RP can be relatively slow, annual changes can be difficult to monitor during the course of a clinical trial. Here we suggest a quick, effective, and reliable method for detecting subtle changes.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Natural history and clinical biomarkers of progression in X-linked retinitis pigmentosa: a systematic review
    Zada, Mark
    Cornish, Elisa E.
    Fraser, Clare L.
    Jamieson, Robyn, V
    Grigg, John R.
    ACTA OPHTHALMOLOGICA, 2021, 99 (05) : 499 - 510
  • [2] A Comparison of Progressive Loss of the Ellipsoid Zone (EZ) Band in Autosomal Dominant and X-Linked Retinitis Pigmentosa
    Cai, Cindy X.
    Locke, Kirsten G.
    Ramachandran, Rithambara
    Birch, David G.
    Hood, Donald C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (11) : 7417 - 7422
  • [3] Gene therapy for the treatment of X-linked retinitis pigmentosa
    De La Camara, Cristina Martinez-Fernandez
    Nanda, Anika
    Salvetti, Anna Paola
    Fischer, M. Dominik
    MacLaren, Robert E.
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (03): : 167 - 177
  • [4] Phenotypic progression in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene
    Al-Maskari, A.
    OGrady, A.
    Pal, B.
    McKibbin, M.
    EYE, 2009, 23 (03) : 519 - 521
  • [5] Long-Term Visual Field Progression in X-Linked Retinitis Pigmentosa Patients
    Steensberg, Alvilda Hemmingsen
    Al-Hamdani, Sermed
    Hansen, Michael Stormly
    Klefter, Oliver Niels
    Bertelsen, Mette
    Hamann, Steffen
    DIAGNOSTICS, 2024, 14 (24)
  • [6] Phenotypic progression in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene
    A Al-Maskari
    A O'grady
    B Pal
    M McKibbin
    Eye, 2009, 23 : 519 - 521
  • [7] A SYSTEMATIC LITERATURE REVIEW OF DISEASE PROGRESSION REPORTED IN RPGR-ASSOCIATED X-LINKED RETINITIS PIGMENTOSA
    Lam, Byron L.
    Scholl, Hendrik P. N.
    Doub, Daneal
    Sperling, Marvin
    Hashim, Mahmoud
    Li, Nan
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (01): : 1 - 9
  • [8] X-Linked Retinitis Pigmentosa Gene Therapy: Preclinical Aspects
    Vahid Mansouri
    Ophthalmology and Therapy, 2023, 12 : 7 - 34
  • [9] Evaluation of multimodal imaging in carriers of X-linked retinitis pigmentosa
    Acton, Jennifer H.
    Greenberg, Jonathan P.
    Greenstein, Vivienne C.
    Marsiglia, Marcela
    Tabacaru, Mirela
    Smith, R. Theodore
    Tsang, Stephen H.
    EXPERIMENTAL EYE RESEARCH, 2013, 113 : 41 - 48